17 alpha-hydroxylase deficiency pathophysiology: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
 
(20 intermediate revisions by 4 users not shown)
Line 2: Line 2:
{{17 alpha-hydroxylase deficiency}}
{{17 alpha-hydroxylase deficiency}}
{{CMG}}; {{AE}} {{MJ}}
{{CMG}}; {{AE}} {{MJ}}
==Overview==
==Overview==
17α-hydroxylase deficiency is an uncommon form of [[congenital adrenal hyperplasia]] resulting from a defect in the [[gene]] ''[[CYP17A1]]'', which encodes for the [[enzyme]] 17α-hydroxylase. Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency is transmitted in an autosomal recessive pattern. On gross pathology, thickening of the [[adrenal gland]] and cerebriform appearance are characteristic findings of congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency. On microscopic histopathological analysis, diffuse cortical hyperplasia and lipid-depleted cortical cells are characteristic findings of congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency.
17 alpha-hydroxylase deficiency is an uncommon form of [[congenital adrenal hyperplasia]] resulting from a defect in the [[gene]] [[CYP17A1]], which encodes for the [[enzyme]] 17 alpha-hydroxylase and 17,20-lyase. 17 alpha-hydroxylase deficiency is transmitted in an [[autosomal recessive]] pattern. [[Mineralocorticoid excess]] and lack of [[androgens]] are two main features in this disease.  
==Pathogenesis==
==Pathogenesis==
* 17 alpha-hydroxylase deficiency results in a decreased synthesis of both [[cortisol]] and [[sex steroid]]s, in addition to an increase in [[mineralocorticoid]] production. Thus, common symptoms include mild [[hypocortisolism]], [[ambiguous genitalia]] in genetic males or failure of the ovaries to function at puberty in genetic females, and [[hypertension]].
* [[CYP17A1]] gene defects can cause two type of enzyme deficiencies: 17α-hydroxylase enzyme deficiency and 17,20-lyase deficiency. The dual activities mediate key transformations in [[cortisol]] and [[sex steroid]] synthesis:
* This form of congenital adrenal hyperplasia results from deficiency of the [[enzyme]] [[17α-hydroxylase]] (also called [[CYP17A1]]).<ref name="w"> Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency. Wikipedia (2016. https://en.wikipedia.org/wiki/Congenital_adrenal_hyperplasia_due_to_17_alpha-hydroxylase_deficiency  Accessed on February 4, 2016</ref>
** 17α-hydroxylase mediates the pathway: [[pregnenolone]] → [[17-hydroxypregnenolone]], also [[progesterone]] → [[17-hydroxyprogesterone]].
* 17α-hydroxylase deficiency impairs the efficiency of [[cortisol]] synthesis, resulting in high levels of [[adrenocorticotropic hormone]] secretion and hyperplasia of the adrenal glands.
** 17,20-lyase mediates pathway [[17-hydroxypregnenolone]] → [[DHEA|Dehydroepiandrosterone]], also [[17-hydroxyprogesterone]] → [[androstenedione]].
* Clinical effects of this condition include overproduction of [[mineralocorticoid]]s and deficiency of prenatal and [[puberty|pubertal]] [[sex steroid]]s. CYP17A1 functions in [[steroidogenesis]], where it converts [[pregnenolone]] and [[progesterone]] to their 17-hydroxy forms. The enzyme itself is attached to the smooth [[endoplasmic reticulum]] of the steroid-producing cells of the [[adrenal gland|adrenal cortex]] and [[gonad]]s. CYP17A1 functions as both a 17α-hydroxylase and a 17,20-lyase. The dual activities mediate three key transformations in [[cortisol]] and [[sex steroid]] synthesis:
* [[Mineralocorticoid excess]] is the major clinical clue distinguishing the 17α-hydroxylase deficiency from the 17,20-lyase deficiency, which only affects the [[Sex (activity)|sex]] [[steroids]].
* As 17α-hydroxylase it mediates [[pregnenolone]] → [[17-hydroxypregnenolone]] and [[progesterone]] → [[17-hydroxyprogesterone]].
* In 17 alpha-hydroxylase deficiency, [[steroid biosynthesis]] will be limited to [[progesterone]], [[11-deoxycorticosterone]] ([[Deoxycorticosterone|DOC]]), and [[corticosterone]].
* As 17,20-lyase it mediates 17-hydroxypregnenolone → [[DHEA|Dehydroepiandrosterone]].
* [[11-deoxycorticosterone]] ([[Deoxycorticosterone|DOC)]] binds to the mineralocorticoid receptor and its excess amounts in 17 alpha-hydroxylase deficiency causes [[aldosterone]] effects such as volume expansion, [[hypertension]], and [[hypokalemia]]. Also, [[11-deoxycorticosterone]] ([[Deoxycorticosterone|DOC)]] effects will suppress [[renin]] and [[aldosterone]] production.
* An expected second 17,20-lyase reaction (17-hydroxyprogesterone → [[androstenedione]]) is mediated so inefficiently in humans as to be of no known significance.
* The most important features of 17 alpha-hydroxylase deficiency include [[hypertension]], [[hypokalemia]] and [[sexual infantilism]].
* The hydroxylase reactions are part of the synthetic pathway to cortisol as well as sex steroids, but the lyase reaction is only necessary for sex steroid synthesis.
** [[Hypertension]] and [[hypokalemia]] result from accumulation of [[cortisol]] precursors, that have [[mineralocorticoid]] characteristics.
* The dual enzyme activities were for many decades assumed to represent two entirely different genes and enzymes: 7α-hydroxylase deficient congenital adrenal hyperplasia, and a distinct and even rarer defect of sex steroid synthesis termed 17,20-lyase deficiency. In the last decade, it has become clear that the two diseases are different forms of defects of the same gene. However, the clinical features of the two types of impairment are distinct enough that they are described separately in the following sections.
** [[Sexual infantilism]] results from the inability of [[adrenal cortex]] to synthesize [[androgens]] and [[estrogens]].<ref name="pmid8070426">{{cite journal |vauthors=Kater CE, Biglieri EG |title=Disorders of steroid 17 alpha-hydroxylase deficiency |journal=Endocrinol. Metab. Clin. North Am. |volume=23 |issue=2 |pages=341–57 |year=1994 |pmid=8070426 |doi= |url=}}</ref><ref name="pmid999330">{{cite journal |vauthors=Heremans GF, Moolenaar AJ, van Gelderen HH |title=Female phenotype in a male child due to 17-alpha-hydroxylase deficiency |journal=Arch. Dis. Child. |volume=51 |issue=9 |pages=721–3 |year=1976 |pmid=999330 |pmc=1546244 |doi= |url=}}</ref><ref name="pmid9452426">{{cite journal |vauthors=Auchus RJ, Lee TC, Miller WL |title=Cytochrome b5 augments the 17,20-lyase activity of human P450c17 without direct electron transfer |journal=J. Biol. Chem. |volume=273 |issue=6 |pages=3158–65 |year=1998 |pmid=9452426 |doi= |url=}}</ref><ref name="pmid6332824">{{cite journal |vauthors=Griffing GT, Wilson TE, Holbrook MM, Dale SL, Jackson TK, Ullrich I, Melby JC |title=Plasma and urinary 19-nor-deoxycorticosterone in 17 alpha-hydroxylase deficiency syndrome |journal=J. Clin. Endocrinol. Metab. |volume=59 |issue=5 |pages=1011–5 |year=1984 |pmid=6332824 |doi=10.1210/jcem-59-5-1011 |url=}}</ref><ref name="pmid15866602">{{cite journal |vauthors=Simsek E, Ozdemir I, Lin L, Achermann JC |title=Isolated 17,20-lyase (desmolase) deficiency in a 46,XX female presenting with delayed puberty |journal=Fertil. Steril. |volume=83 |issue=5 |pages=1548–51 |year=2005 |pmid=15866602 |doi=10.1016/j.fertnstert.2004.11.063 |url=}}</ref>
===Mineralocorticoid Effects===
 
* The adrenal cortex is hyperplastic and overstimulated, with no impairment of the mineralocorticoid pathway. Consequently, levels of deoxycorticosterone, [[corticosterone]], and 18-deoxycorticosterone are elevated. Although these precursors of [[aldosterone]] are weaker mineralocorticoids, the extreme elevations usually provide enough volume expansion, blood pressure elevation, and potassium depletion to suppress [[renin]] and aldosterone production. Some persons with 17α-hydroxylase deficiency develop [[hypertension]] in infancy, and nearly 90% do so by late childhood. The low-renin [[hypertension]] is often accompanied by [[hypokalemia]] due to urinary potassium wasting and [[metabolic alkalosis]]. These features of mineralocorticoid excess are the major clinical clue distinguishing the more complete 17α-hydroxylase deficiency from the 17,20-lyase deficiency, which only affects the sex steroids. Treatment with glucocorticoid suppresses ACTH, returns mineralocorticoid production toward normal, and lowers blood pressure.
[[image:17 hydroxylase.gif|center|frame|800px|Adrenal steroid synthesis pathways in adrenal cortex and related enzymes <ref name="urlFile:Adrenal Steroids Pathways.svg - Wikimedia Commons">{{cite web |url=https://commons.wikimedia.org/wiki/File:Adrenal_Steroids_Pathways.svg|title=File:Adrenal Steroids Pathways.svg - Wikimedia Commons |format= |work= |accessdate=}}</ref>]]
[[Image:Steroidogenesis.png|thumb|center|800px|Production of DHEA from Cholesterol. ([[Cortisol]] is a [[glucocorticoid]].)]]
 
===Glucocorticoid Effects===
* Although production of cortisol is inefficient enough to normalize ACTH, the 50-100-fold elevations of [[corticosterone]] have enough weak [[glucocorticoid]] activity to prevent glucocorticoid deficiency and adrenal crisis.
===Sex Steroid Effects===
* Genetic XX females affected by 17α-hydroxylase deficiency are born with normal female internal and external anatomy. At the expected time of [[puberty]], neither the adrenals nor the ovaries can produce sex steroids, so neither breast development nor pubic hair appears. Investigation of delayed puberty yields elevated [[gonadotropin]]s and normal karyotype while imaging confirms the presence of ovaries and an infantile uterus. Discovery of hypertension and hypokalemic [[alkalosis]] usually suggests the presence of one of the proximal forms of congenital adrenal hyperplasia, and the characteristic mineralocorticoid elevations confirm the specific diagnosis.
* A few milder forms of this deficiency in genetic females have allowed relatively normal breast development and irregular menstruation. Evidence suggests that only 5% of normal enzyme activity may be enough to allow at least the physical changes of female puberty, if not [[ovulation]] and fertility. In these girls, the elevated blood pressure was the primary clinical problem.
* 17α-Hydroxylase deficiency in genetic males (XY) results in moderate to severe reduction of fetal [[testosterone]] production by both adrenals and testes. [[virilization|Undervirilization]] is variable and sometimes complete. The appearance of the external [[genitalia]] ranges from normal female to ambiguous to mildly underdeveloped male. The most commonly described phenotype is a small [[phallus]], [[perineum|perineal]] [[hypospadias]], small blind pseudovaginal pouch, and intra-abdominal or [[inguinal canal|inguinal]] testes. [[Wolffian duct]] derivatives are hypoplastic or normal, depending on the degree of testosterone deficiency. Some of those with partial virilization develop [[gynecomastia]] at puberty even though masculinization is reduced. The presence of hypertension in the majority distinguishes them from other forms of partial androgen deficiency or [[androgen insensitivity syndrome|insensitivity]]. Fertility is impaired in those with more than minimal testosterone deficiency.
==17,20-Lyase Deficiency==
* A very small number of people have reportedly had an abnormal allele that resulted primarily in a reduction of 17,20-lyase activity, rather than both the hydroxylase and lyase activities. In these people the defect had the effect of an isolated impairment of [[sex steroid]] synthesis, whereas [[mineralocorticoid]] (e.g., aldosterone) and [[glucocorticoid]] levels remain normal.  
* Normal [[aldosterone]] level can be attributed to the fact that aldosterone is independent of hypothalamus-pituitary axis feedback system, being mainly controlled by the level of serum potassium. Because of the normal [[aldosterone]] level, [[hypertension]] is not expected.
* Normal [[cortisol]] level can be explained by the strong negative feedback mechanism of [[cortisol]] on hypothalamus-pituitary axis system. That is, in the beginning, the 17,20-lyase deficiency will block synthesis of sex steroid hormones, forcing the pathways to produce more [[cortisol]]. However, the initial excess of cortisol is rapidly corrected by negative feedback mechanism—high cortisol decreases secretion of [[adrenocorticotropic hormone]] (ACTH) from zona fasciculata of [[adrenal gland]]. Thus, there is no mineralocorticoid overproduction. Also, there is no adrenal hyperplasia.
* It has also been observed in patients that the [[adrenocorticotropic hormone]] (ACTH) level remains in the normal range. The reason for this is still unclear.
* The sex steroid deficiency produces effects similar to 17α-hydroxylase deficiency. Severely affected genetic females (XX) are born with normal internal and external genitalia and there are no clues to abnormality until adolescence when both the androgenic and estrogenic signs (e.g., [[breast]] and pubic hair) of puberty fail to occur. Gonadotropins are high and the [[uterus]] infantile in size. The ovaries may contain enlarged follicular cysts, and ovulation may not occur even after replacement of [[estrogen]].
==Genetics==
==Genetics==
* Congenital adrenal hyperplasia due to 17α-hydroxylase deficiency is inherited in an [[autosomal recessive]] manner. The most common abnormal [[allele]]s of this condition impair both the 17α-hydroxylase activity and the 17,20-lyase activity of CYP17A1.
* 17 alpha-hydroxylase deficiency is an [[inherited]] disease with an [[autosomal recessive]] pattern, which means both copies of the [[gene]] in each [[cell]] have [[gene]] [[mutations]].  
[[Image:Autorecessive.png|thumb|center|600px|11β-OH CAH is autosomal recessive]]
* Commonly, the parents of an individual with an [[autosomal recessive]] condition each carry one copy of the mutated [[gene]], but they typically do not show signs and symptoms of the condition.<ref name="pmid28476231">{{cite journal |vauthors=Hannah-Shmouni F, Chen W, Merke DP |title=Genetics of Congenital Adrenal Hyperplasia |journal=Endocrinol. Metab. Clin. North Am. |volume=46 |issue=2 |pages=435–458 |year=2017 |pmid=28476231 |doi=10.1016/j.ecl.2017.01.008 |url=}}</ref>
 
==Associated Conditions==
==Associated Conditions==
* [[Metabolic alkalosis]]
* [[Ambiguous genitalia]]
* [[Hypokalemia]]
* [[Hypertension]]
* [[Abdominal hernia]]
 
==Gross Pathology==
==Gross Pathology==
* On gross pathology the following changes are noted:
[[Gross pathology]] findings in patients with 17 alpha-hydroxylase deficiency are:<ref name="radio">Congenital adrenal hyperplasia. Dr Henry Knipe and Dr M Venkatesh . Radiopaedia.org 2015.http://radiopaedia.org/articles/congenital-adrenal-hyperplasia</ref><ref name="pmid25372578">{{cite journal |vauthors=Teixeira SR, Elias PC, Andrade MT, Melo AF, Elias Junior J |title=The role of imaging in congenital adrenal hyperplasia |journal=Arq Bras Endocrinol Metabol |volume=58 |issue=7 |pages=701–8 |year=2014 |pmid=25372578 |doi= |url=}}</ref>
:* Thickening of adrenal gland<ref> Adrenocortical hyperplasia. American urological association (2016). https://www.auanet.org/education/modules/pathology/adrenal-gland/hyperplasia.cfm Accessed on January 28, 2016</ref>
*Enlarged [[adrenal glands]]
:* Cerebriform appearance
*Wrinkled surface [[adrenal glands]]
*Cerebriform pattern [[adrenal glands]] ([[pathognomonic]] sign)
*Normal [[ultrasound]] appearances may also be seen
*[[Testicular]] masses may be identified representing [[adrenal]] rest tissue
[[Image:Cah.jpg|center|thumb|400px|frame|Adrenal gland, Cortex - Hyperplasia in a male rat from a chronic study. There are two adjacent foci of hyperplasia (H) in the zona fasciculata.<ref name="urlAdrenal Gland - Hyperplasia - Nonneoplastic Lesion Atlas">{{cite web |url=https://ntp.niehs.nih.gov/nnl/endocrine/adrenal/hyperpl/index.htm |title=Adrenal Gland - Hyperplasia - Nonneoplastic Lesion Atlas |format= |work= |accessdate=}}</ref>]]
 
==Microscopic Pathology==
==Microscopic Pathology==
* On microscopic pathology the following changes are noted:
In 17 alpha-hydroxylase deficiency [[microscopic]] findings may include:
:* Diffuse cortical hyperplasia
* Diffuse cortical [[hyperplasia]] with smaller [[cells]]
:* Zona reticularis is markedly hyperplastic
* The cell [[cytoplasm]] can be vacuolated, and often more [[basophilic]]
:* Lipid-depleted cortical cells
* Rare [[mitotic]] figures may be present
* The [[hyperplastic]] cells typically lack features of cellular [[atypia]]<ref name="urlAdrenal Gland - Hyperplasia - Nonneoplastic Lesion Atlas">{{cite web |url=https://ntp.niehs.nih.gov/nnl/endocrine/adrenal/hyperpl/index.htm |title=Adrenal Gland - Hyperplasia - Nonneoplastic Lesion Atlas |format= |work= |accessdate=}}</ref>
[[Image:Cah mic.jpg|thumb|center|400px|frame|Adrenal gland, Cortex - Hyperplasia in a female rat from a chronic study. There is a hyperplastic lesion (H) in which cortical cells are increased in number but are smaller in size than adjacent normal cortical cells (NC)<ref name="urlAdrenal Gland - Hyperplasia - Nonneoplastic Lesion Atlas">{{cite web |url=https://ntp.niehs.nih.gov/nnl/endocrine/adrenal/hyperpl/index.htm |title=Adrenal Gland - Hyperplasia - Nonneoplastic Lesion Atlas |format= |work= |accessdate=}}</ref>]]
 
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
[[Category:Disease]]
[[Category:Pediatrics]]
[[Category:Endocrinology]]
[[Category:Genetic disorders]]
[[Category:Intersexuality]]
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}

Latest revision as of 16:04, 20 October 2017

Congenital adrenal hyperplasia main page

17 alpha-hydroxylase deficiency Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating 17 alpha-hydroxylase deficiency from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

17 alpha-hydroxylase deficiency pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of 17 alpha-hydroxylase deficiency pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on 17 alpha-hydroxylase deficiency pathophysiology

CDC on 17 alpha-hydroxylase deficiency pathophysiology

17 alpha-hydroxylase deficiency pathophysiology in the news

Blogs on 17 alpha-hydroxylase deficiency pathophysiology

Directions to Hospitals Treating Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency

Risk calculators and risk factors for 17 alpha-hydroxylase deficiency pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mehrian Jafarizade, M.D [2]

Overview

17 alpha-hydroxylase deficiency is an uncommon form of congenital adrenal hyperplasia resulting from a defect in the gene CYP17A1, which encodes for the enzyme 17 alpha-hydroxylase and 17,20-lyase. 17 alpha-hydroxylase deficiency is transmitted in an autosomal recessive pattern. Mineralocorticoid excess and lack of androgens are two main features in this disease.

Pathogenesis

Adrenal steroid synthesis pathways in adrenal cortex and related enzymes [6]

Genetics

Associated Conditions

Gross Pathology

Gross pathology findings in patients with 17 alpha-hydroxylase deficiency are:[8][9]

Adrenal gland, Cortex - Hyperplasia in a male rat from a chronic study. There are two adjacent foci of hyperplasia (H) in the zona fasciculata.[10]

Microscopic Pathology

In 17 alpha-hydroxylase deficiency microscopic findings may include:

Adrenal gland, Cortex - Hyperplasia in a female rat from a chronic study. There is a hyperplastic lesion (H) in which cortical cells are increased in number but are smaller in size than adjacent normal cortical cells (NC)[10]

References

  1. ↑ Kater CE, Biglieri EG (1994). "Disorders of steroid 17 alpha-hydroxylase deficiency". Endocrinol. Metab. Clin. North Am. 23 (2): 341–57. PMID 8070426.
  2. ↑ Heremans GF, Moolenaar AJ, van Gelderen HH (1976). "Female phenotype in a male child due to 17-alpha-hydroxylase deficiency". Arch. Dis. Child. 51 (9): 721–3. PMC 1546244. PMID 999330.
  3. ↑ Auchus RJ, Lee TC, Miller WL (1998). "Cytochrome b5 augments the 17,20-lyase activity of human P450c17 without direct electron transfer". J. Biol. Chem. 273 (6): 3158–65. PMID 9452426.
  4. ↑ Griffing GT, Wilson TE, Holbrook MM, Dale SL, Jackson TK, Ullrich I, Melby JC (1984). "Plasma and urinary 19-nor-deoxycorticosterone in 17 alpha-hydroxylase deficiency syndrome". J. Clin. Endocrinol. Metab. 59 (5): 1011–5. doi:10.1210/jcem-59-5-1011. PMID 6332824.
  5. ↑ Simsek E, Ozdemir I, Lin L, Achermann JC (2005). "Isolated 17,20-lyase (desmolase) deficiency in a 46,XX female presenting with delayed puberty". Fertil. Steril. 83 (5): 1548–51. doi:10.1016/j.fertnstert.2004.11.063. PMID 15866602.
  6. ↑ "File:Adrenal Steroids Pathways.svg - Wikimedia Commons".
  7. ↑ Hannah-Shmouni F, Chen W, Merke DP (2017). "Genetics of Congenital Adrenal Hyperplasia". Endocrinol. Metab. Clin. North Am. 46 (2): 435–458. doi:10.1016/j.ecl.2017.01.008. PMID 28476231.
  8. ↑ Congenital adrenal hyperplasia. Dr Henry Knipe and Dr M Venkatesh . Radiopaedia.org 2015.http://radiopaedia.org/articles/congenital-adrenal-hyperplasia
  9. ↑ Teixeira SR, Elias PC, Andrade MT, Melo AF, Elias Junior J (2014). "The role of imaging in congenital adrenal hyperplasia". Arq Bras Endocrinol Metabol. 58 (7): 701–8. PMID 25372578.
  10. ↑ 10.0 10.1 10.2 "Adrenal Gland - Hyperplasia - Nonneoplastic Lesion Atlas".
Retrieved from "https://www.wikidoc.org/index.php?title=17_alpha-hydroxylase_deficiency_pathophysiology&oldid=1377715"